SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FISHERMAN who wrote (220)11/28/1997 7:09:00 AM
From: 5,17,37,5,101,...  Read Replies (1) of 756
 
Interesting tidbit on initial impetus of the fall of Ivax of which I'm sure you are fully aware:

securities.stanford.edu

The write off for "price protection" was much smaller this quarter indicating that prices have stabilized though at lower levels. Customers are no longer requesting rebates. Sales increased by 20+% but did the share price rise ... no; margins are way too low. We need new drug (preferrably proprietary) approval to make money. Mylan is doing this. Ivax cannot rely on improved pricing.

Jackson
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext